CHANTIX (Pfizer Laboratories Div Pfizer Inc)
Welcome to the PulseAid listing for the CHANTIX drug offered from Pfizer Laboratories Div Pfizer Inc. This Partial Cholinergic Nicotinic Agonist [EPC],Partial Cholinergic Nicotinic Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc |
NON-PROPRIETARY NAME: | varenicline tartrate |
SUBSTANCE NAME: | VARENICLINE TARTRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Partial Cholinergic Nicotinic Agonist [EPC],Partial Cholinergic Nicotinic Agonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2006-05-10 |
END MARKETING DATE: | 0000-00-00 |
CHANTIX HUMAN PRESCRIPTION DRUG Details:
Item Description | CHANTIX from Pfizer Laboratories Div Pfizer Inc |
LABELER NAME: | Pfizer Laboratories Div Pfizer Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/1) |
START MARKETING DATE: | 2006-05-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0069-0468_751b8e6f-c868-4077-826a-a70983951c11 |
PRODUCT NDC: | 0069-0468 |
APPLICATION NUMBER: | NDA021928 |
Other VARENICLINE TARTRATE Pharmaceutical Manufacturers / Labelers: